Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Graft vs Host Disease × Interferon-gamma × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Myelodysplastic Syndromes 1 Graft vs Host Disease 1

Interventions

ruxolitinib 4 Cyclophosphamide 4 Mycophenolic Acid 3 fludarabine 2 Tacrolimus 2 Methotrexate 2 Busulfan 2 blinatumomab 1 belumosudil 1 axatilimab 1 Whole-Body Irradiation 1 Vorinostat 1 Thiotepa 1 Sirolimus 1 Panobinostat 1 Low-Level Light Therapy 1 Interferon-gamma 1 Cyclosporine 1 Clofarabine 1 Blood Specimen Collection 1 Biopsy 1 Adrenal Cortex Hormones 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04328714 2026-02-13

Interferon γ-Primed Mesenchymal Stromal Cells as Prophylaxis for Acute Graft v Host Disease

Emory University

Phase 1 Terminated

Graft vs Host Disease, Myelodysplastic Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon ⚡